TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis

Overview of attention for article published in Frontiers in endocrinology, May 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,333 followers.

RT @Dr_MSU: @nihar_nayak2 🤔 (T)alenjiectasis ➡️ Pulmonary arteriovenous malformations ➡️ (E)levated EPO ➡️ Polycytemia ➕ (M)onoclonal gamm…

14 Apr 2023

Reply Repost Favourite

RT @Dr_MSU: @nihar_nayak2 🤔 (T)alenjiectasis ➡️ Pulmonary arteriovenous malformations ➡️ (E)levated EPO ➡️ Polycytemia ➕ (M)onoclonal gamm…

12 Apr 2023

Reply Repost Favourite

@nihar_nayak2 🤔 (T)alenjiectasis ➡️ Pulmonary arteriovenous malformations ➡️ (E)levated EPO ➡️ Polycytemia ➕ (M)onoclonal gammopathy ➕ (P)erinephric fluid ↪️ (I)ntrapulmonary right-to-left shunts; so called TEMPI Syndrome. ‼️Usually IgG Kappa. https://t

12 Apr 2023

Reply Repost Favourite

New Research: TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis: TEMPI (telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and… https://t.co/aAuEwSTMfo #Endocrino

19 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.